We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+9.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$24.1B
AUM Growth
-$134M
Cap. Flow
-$2.11B
Cap. Flow %
-8.76%
Top 10 Hldgs %
23.77%
Holding
1,984
New
527
Increased
347
Reduced
445
Closed
587

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$157M
2
TMO icon
Thermo Fisher Scientific
TMO
+$135M
3
CRM icon
Salesforce
CRM
+$135M
4
IBM icon
IBM
IBM
+$130M
5
DELL icon
Dell
DELL
+$114M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$313M
2
AAPL icon
Apple
AAPL
+$207M
3
INTC icon
Intel
INTC
+$183M
4
BMY icon
Bristol-Myers Squibb
BMY
+$159M
5
CNC icon
Centene
CNC
+$152M

Sector Composition

Rank Sector Weight
1 Healthcare 23.31%
2 Technology 17.95%
3 Communication Services 13.61%
4 Consumer Discretionary 12.67%
5 Financials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRIP icon
1776
TripAdvisor
TRIP
$1.26B
-61,216
Closed -$3.29M
TRMB icon
1777
Trimble
TRMB
$13.9B
-66,032
Closed -$5.14M
TROW icon
1778
T. Rowe Price
TROW
$24.3B
-125,680
Closed -$21.6M
TROX icon
1779
Tronox
TROX
$1.04B
-502,135
Closed -$9.19M
TSM icon
1780
TSMC
TSM
$2.18T
-348,509
Closed -$41.2M
TTEK icon
1781
Tetra Tech
TTEK
$9.07B
-15,680
Closed -$426K
TU icon
1782
Telus
TU
$15.3B
-1,317,030
Closed -$26.2M
TVTX icon
1783
Travere Therapeutics
TVTX
$5.78B
-58,152
Closed -$1.45M
TW icon
1784
Tradeweb Markets
TW
$21.6B
-144,176
Closed -$10.7M
TYL icon
1785
Tyler Technologies
TYL
$12.8B
-5,097
Closed -$2.16M
UGI icon
1786
UGI
UGI
$7.33B
-65,758
Closed -$2.7M
UHAL icon
1787
U-Haul Holding Co
UHAL
$14.6B
-4,430
Closed -$272K
UMH
1788
UMH Properties
UMH
$1.36B
-13,645
Closed -$262K
UNFI icon
1789
United Natural Foods
UNFI
$2.85B
-148,302
Closed -$4.88M
UPST icon
1790
Upstart Holdings
UPST
$3.03B
-3,891
Closed -$501K
USB icon
1791
US Bancorp
USB
$99.6B
-5,854
Closed -$323K
UTHR icon
1792
United Therapeutics
UTHR
$23.1B
-272,286
Closed -$45.5M
VCYT icon
1793
Veracyte
VCYT
$3.8B
-37,225
Closed -$2M
VECO icon
1794
Veeco
VECO
$3.23B
-61,581
Closed -$1.28M
VERI icon
1795
Veritone
VERI
$122M
-56,376
Closed -$1.35M
VIR icon
1796
Vir Biotechnology
VIR
$1.49B
-106,594
Closed -$5.46M
VIOT
1797
Viomi Technology
VIOT
$49.2M
-12,090
Closed -$109K
VIV icon
1798
Telefônica Brasil
VIV
$19.2B
-23,048
Closed -$181K
VMD icon
1799
Viemed Healthcare
VMD
$371M
-12,300
Closed -$125K
VMI icon
1800
Valmont Industries
VMI
$9.53B
-7,298
Closed -$1.74M

Similar funds

Marshall Wace North America's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace North America held 1,984 positions worth $24.1B, down 0.56% from $24.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Marshall Wace North America withdrew a net $2.11B in Q2 2021, closing 587 positions and reducing 445 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $119M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Marshall Wace North America opened a new position in Syneos Health, Inc. Class A Common Stock worth $83.7M.

  • Marshall Wace North America's largest Q2 2021 buy was Syneos Health, Inc. Class A Common Stock: 935,304 shares worth $83.7M.
  • Marshall Wace North America added most to Johnson & Johnson in Q2 2021, an estimated $157M increase.
  • Marshall Wace North America's biggest Q2 2021 reduction was Microsoft, cutting an estimated $313M.
  • Marshall Wace North America fully exited State Street SPDR S&P 500 ETF Trust in Q2 2021, selling an estimated $119M.
  • Marshall Wace North America's ten largest holdings make up 24% of its $24.1B portfolio in Q2 2021.
  • Marshall Wace North America opened 527 new positions and closed 587 in Q2 2021.
  • Marshall Wace North America's portfolio value fell 0.56% quarter-over-quarter to $24.1B.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.